Laurion Capital Management is a hedge fund in New York that focuses on managing assets for foundations, endowments, family offices, pension funds, and other institutional and individual investors. Founded 2005 in New York, United States, it invests in series E and series B rounds. Its portfolio companies include Schrodinger and SpringWorks Therapeutics. As of March 2020, Laurion Capital Management has made two investments. Their most recent investment was on May 19, 2019, when Schrodinger raised $25M. Laurion Capital Management has had two exits, the most notable of which include Schrodinger and SpringWorks Therapeutics.
Documentaries, videos and podcasts